FDA — authorised 6 September 1973
- Marketing authorisation holder: MERCK
- Status: approved
🇺🇸 Decadron-La in United States
FDA authorised Decadron-La on 6 September 1973
Marketing authorisations
FDA — authorised 6 September 1973
- Application: NDA016675
- Marketing authorisation holder: MERCK
- Local brand name: DECADRON-LA
- Indication: INJECTABLE — INJECTION
- Status: approved
Decadron-La in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Decadron-La approved in United States?
Yes. FDA authorised it on 6 September 1973; FDA authorised it on 6 September 1973.
Who is the marketing authorisation holder for Decadron-La in United States?
MERCK holds the US marketing authorisation.